CS Paper Radar

Label-Free Coreset Selection with Foundation Models for Efficient Annotation in Computational Pathology

Tuo Yin, Jennifer Dhont

cs.CV ·submitted 2026-10-05 08:40 UTC · v1
code/data

Abstract

Computational pathology has the potential to improve clinical outcomes through a demonstrated increase in diagnostic and prognostic accuracy. However, the development and validation of deep learning algorithms still require annotated data, a costly procedure involving expert pathologists who already face critical workforce shortages. Existing coreset selection methods to optimize annotation efforts currently all rely on hyperparameters tuned on natural-image benchmarks that do not transfer to histopathology and are cumbersome to use in clinical practice. In this study, we present GCcore, a novel label-free coreset selection method that embeds every image of a dataset with any pathology foundation model and greedily selects the samples that collectively maximize the global coverage of the embedding space. The proposed method provides a lower-bound guarantee on the global coverage of the returned coreset for any coreset size, while being completely hyperparameter-free and deterministic. We demonstrate GCcore's superior performance over 14 baselines including state-of-the-art methods across 10 tasks and datasets spanning whole slide image classification, tile classification, and tissue segmentation, where it ranks first on six and within the top three on nine, while also demonstrating how existing methods can shift by up to five rank positions depending on their hyperparameter settings. Code is publicly available at https://github.com/OncoAI-ULBHUB/GCcore.

Comment
32 pages, 7 figures

Closest papers

Nearest neighbours by meaning across the whole index.

Foundation Model-Enabled Efficient Data Sampling (FEEDS): A label-efficient training strategy for pan-cancer, multi-tracer PET/CT datasets

cs.CV ·2026-08-11 ·Biratal Raj Wagle, Bashirul Azam Biswas, Grant Chau, Matthew E. Maeder, Muhammad Azeem Arshad +3 more
code/data similarity 0.76
Abstract · Code is publicly available on https://github.com/Image-and-Multimodal-Data-Analytics/FEEDS

Automated lesion segmentation in whole-body PET/CT imaging can assist clinicians with cancer detection, staging, and treatment planning across radiotracers and cancer types. However, training lesion segmentation models that capture variations in lesion size, distribution, and appearance requires large annotated datasets, whose creation is both time- and expertise-intensive. As a result, models trained on limited labeled PET/CT data often lack the accuracy and generalizability needed for clinical use. We present FEEDS (Foundation model-Enabled Efficient Data Sampling), a label- and compute-efficient learning strategy that uses vision foundation model embeddings to select the most informative and diverse unlabeled cases for expert annotation. Unlike unsupervised, semi-supervised, and active learning approaches, FEEDS is a one-step training paradigm requiring only a limited, representative training set, making it label- and compute-efficient. We train and validate FEEDS using the AutoPET-III dataset. We test its accuracy and generalizability on three held-out sets: AutoPET-III, DeepPSMA, and an internal Dartmouth-Hitchcock Medical Center dataset. We evaluate clinical utility at the voxel, lesion, and anatomic region level to assess performance in high-risk areas and treatment planning utility. FEEDS outperforms random-sampling-based labeling, pseudolabel-based semi-supervised learning, and training with limited labeled data alone. It generalizes across all three test sets, FDG and PSMA tracers, and multiple diseases, matching fully-labeled (100\%) training performance with 70\% less annotation burden. FEEDS addresses the challenge of label scarcity in an automatic lesion segmentation framework by providing a practical approach for constructing representative and diverse annotation queues from large, unannotated clinical repositories.

0.59

HERO: Histology Encoder for Robust Representation in Oncology

cs.CV ·2026-09-28 ·Zhi Li, Eghbal Amidi, Yating Cheng, Tyson Dawson, Gorkem Can Ates +9 more
benchmarkcode/data similarity 0.72
Abstract · 22 pages, 4 figures, 13 tables; author information updated; scientific content unchanged

Foundation models trained on large pathology image corpora now provide strong, transferable representations for computational pathology. Over the past few years a series of such models has been released, each trained on more slides than the last; on standard classification and segmentation benchmarks, the leading models are now separated by small margins. In clinical use, however, the foundation model is applied to images from hospitals, scanners, and staining protocols outside its training data. Encoders generally embed these acquisition factors alongside biological information, which may introduce downstream errors and hinder safe clinical adoption. A pathology foundation model should therefore be robust to acquisition shift without giving up representation quality, yet robustness is seldom the axis along which models are compared. In this report, we introduce HERO (Histology Encoder for Robust Representation in Oncology), a ViT-G/14 pathology foundation model trained with the DINO and iBOT objectives and refined with high-resolution Gram anchoring on a morphology-balanced corpus of 500 million tiles from approximately 575,000 clinical whole-slide images. Across the evaluated public benchmarks, HERO shows the strongest robustness to center, scanner, and stain variation among the compared state-of-the-art foundation models, performs comparably on tile-level classification, segmentation, and gene-expression prediction, ranks first on average across 39 evaluated slide-level clinical tasks, and, under an equal-weighted framework-level analysis, has the best average rank across the six benchmark frameworks.

0.22

Colorectal Cancer Segmentation with Adaptive Augmentation and Multi-Resolution Ensemble Models

eess.IV cs.AIcs.CV ·2026-09-29 ·Ümit Mert Çağlar, Alptekin Temizel
publishedcode/data similarity 0.71
Abstract · SPIE Eighteenth International Conference on Machine Vision (ICMV 2025), Paris, France

Colorectal cancer (CRC) is the second most deadly and third most common cancer, and the leading cause of death among gastrointestinal cancers. Early diagnosis is crucial for the treatment of this cancer and increasing the survival rates. Although CRC is more common in developed regions, its occurrence is also increasing in developing regions as well. CRC diagnosis relies on histopathology assessment post-biopsy. Automated deep learning algorithms can significantly reduce diagnosis time, enhancing efficiency and supporting timely clinical decisions. We present an automated segmentation pipeline for whole-slide histopathology images that labels tumor grades 1-3 and normal mucosa. It utilizes dense prediction transformers with various encoder backbones, overlapping patches, and test-time augmentation. An adaptive augmentation policy, guided by large language models, further improves training. Top models were ensembled via soft voting, and mask refining post-processing steps, Gaussian blurring, morphological closing, and connected components analysis. On a colorectal cancer grade dataset, our method improved the F1 score from 62.92 to 69.84. Code is available here: github.com/caglarmert/ICIP2025

0.34

PRET is a few-shot system for pan-cancer recognition without example training

cs.CV ·2026-10-18 ·Yi Li, Ziyu Ning, Tianqi Xiang, Qixiang Zhang, Zhihao Lin +15 more
publishedhighly cited similarity 0.71
Abstract · Nature Cancer Accepted

Pathological examination stands as the cornerstone in cancer diagnosis, impacting millions worldwide annually. With the shortage of pathologists globally, artificial intelligence (AI) has emerged rapidly to automate the diagnostics process. However, conventional AI models require substantial labeled data for each disease, posing huge challenges in scalability and practicality. Therefore, we introduce PRET (pan-cancer recognition without examples training), a few-shot system to achieve flexible, scalable, and effective cancer recognition across diverse organs, hospitals and tasks without training. Evaluated on 23 international benchmarks comprising 4,484 whole-slide images, our method outperforms existing approaches across 20 tasks, achieving over 97% area under the curve on 15 benchmarks with a maximum improvement of 36.76%. Notably, PRET delivers clinical-grade diagnostic performance in lymph node metastasis detection using only eight slide examples, outperforming 11 pathologists. By offering a flexible and cost-effective solution for pan-cancer recognition, PRET paves the way for accessible and equitable AI-based pathology systems, particularly benefiting minority populations and underserved regions.

0.46

MI-Hyper: Generating Multiple Instance Models for Weight Space Transfer Learning in Histopathology via Mixed Tasks Pretrained HyperNetwork

cs.CV ·2026-11-17 ·Xitong Ling, Yousef Kotp, Weiming Chen, Yining Li, Jiawen Li +7 more
similarity 0.70
Abstract

Zero-shot whole-slide image (WSI) prediction aims to generalize to new pathology tasks without parameter updates at deployment. MI-Zero makes these predictions by pooling patch-text similarities. Conditional weight generation, combined with supervision from diverse pathology tasks, offers an alternative: learning to construct predictive rules from task descriptions. We introduce MI-Hyper, a hypernetwork pretrained across mixed tasks to generate the aggregation and classification weights of multiple instance learning (MIL) models. We first train the generator and a shared MIL basis jointly using source labels. We then freeze the basis and refine the generator. The generated task weights are reused across cases. Across 308 tasks from 52 pathology datasets, MI-Hyper improves mean AUC, balanced accuracy and macro-F1 over MI-Zero by 1.85, 1.17 and 0.57 percentage points, respectively. On some molecular prediction tasks, both AUC and balanced accuracy improve by more than 20 points. These results support task-conditioned weight generation as a promising approach to weight-space transfer for long-sequence modeling.

0.17

Less Is More in the Long Tail: Stage-Adaptive Sample Selection for Annotation-Efficient Dense Prediction

cs.CV ·2026-09-22 ·Xiaofei Du, Lei Zhang, Shuyu Yan, Manning Wang, Zhijian Song
similarity 0.70
Abstract

Deep learning performance generally improves with increasing training data, yet this scaling is fundamentally constrained by annotation cost in large-scale dense prediction tasks with long-tailed category distributions, where pixel- or voxel-level annotation is prohibitively expensive. We propose SASS (Stage-Adaptive Sample Selection), a stage-adaptive data-selection framework for pool-based active learning in long-tailed dense prediction. SASS combines three components: label-free self-supervised gradient scoring, prior-guided category rebalancing with validation-driven feedback, and stage-adaptive acquisition aligned with model training dynamics. This design avoids candidate ground-truth masks during gradient scoring while making acquisition responsive to long-tail imbalance and evolving representations. We evaluate SASS on a multimodal 3D medical segmentation testbed comprising over 100,000 samples spanning 108 anatomical structures. SASS recovers 98.3% of full-dataset performance with a 40% training-pool annotation budget, outperforming BADGE by 5.1 percentage points. Moreover, SASS exhibits a statistically supported less-is-more pattern, surpassing full-dataset training at the Hard-group level and, at the structure level, for the pancreas and gallbladder. More broadly, SASS shows that annotation-efficient learning depends not only on which samples are selected, but also on how the annotation budget is distributed across categories and when model-derived scores begin to guide selection.

0.18

Deep Learning for Biopsy-Free Subtyping of Basal Cell Carcinoma from Dermatoscopic Images

cs.CV cs.AI ·2026-09-07 ·Alexandros Papadopoulos, Chrysa Episkopou, Ioannis Sarafis, Aimilios Lallas, Anastasios Delopoulos
similarity 0.69
Abstract

Basal Cell Carcinoma (BCC) is the most common type of skin cancer, accounting for nearly 80% of skin cancer di- agnoses. Its optimal clinical management is guided by the distinct histopathologic subtype, with aggressive variants requiring more drastic measures. In current clinical practice, subtyping relies on skin biopsies, a procedure both costly and invasive. In this paper, we conduct a preliminary investigation into using deep learning for BCC subtyping, solely from a single dermatoscopic image of the lesion. Given the limited data at our disposal, we employ pre-trained vision transformers (ViTs), a state-of-the-art family of models highly effective for challenging downstream tasks with limited labeled data. Through repeated stratified k-fold cross-validation, we demonstrate that ViTs can achieve superior performance (AUC 0.784 on a dataset of 1271 dermatoscopic images of various BCC subtypes) over standard CNN-based baselines as well as previously-reported human reader perfor- mance, on the task of differentiating aggressive BCCs from other subtype families. These initial findings highlight the potential of combining deep learning and dermatoscopy to provide a biopsy- free alternative for BCC subtyping, thus aiding in improving treatment planning and patient outcomes.

0.09

How Far from Clinical Deployment? Evaluating the Complete Unsupervised Domain Adaptation Pipeline in Medical Imaging

cs.CV cs.AI ·2026-08-12 ·Yiheng Xiong, Luisa Gallée, Daniel Santak Wolf, Heiko Hillenhagen, Michael Götz
publishedcode/data similarity 0.69
Abstract · Accepted to WACV 2027

Deploying unsupervised domain adaptation (UDA) in clinical practice requires choosing which algorithm to use and which of its trained models to ship. However, the deployment (target) domain is unlabeled, so models cannot be evaluated directly on it, leaving it unclear which to select. We address this by evaluating the complete UDA pipeline, considering both adaptation and label-free selection together. Our study covers eleven clinically relevant cross-domain scenarios from nine medical imaging datasets, with ten UDA algorithms and 13 label-free selection methods (validators), evaluating over 80,000 trained models in total. By this, we find that a capable adapted model usually exists, but identifying it without target labels is difficult: the validator-selected models leave a large and structural target performance gap to the best available one, with no evaluated validator consistently reliable. Towards closing it, we explore two strategies, ensembling and a small target-labeling budget; both narrow this gap but do not close it entirely. Overall, deployable UDA depends on the complete pipeline; addressing the less explored selection step could bring much of current UDA closer to clinical use. Our code is open sourced at \href{https://xiongyiheng.github.io/complete-uda-pipeline-site/}{Project Page}.

0.80